| Code | Display | Comments |
|---|
 34534-8 | 12 lead EKG panel | | |
| 8897-1 | QRS complex Ventricles by EKG | | |
| 8894-8 | P wave Atrium by EKG | | |
| 8625-6 | P-R interval | | |
| 8633-0 | QRS duration | | |
| 8634-8 | Q-T interval | | |
| 8636-3 | Q-T interval corrected | | |
| 8626-4 | P wave axis | | |
| 8632-2 | QRS axis | | |
| 8638-9 | T wave axis | | |
| 8601-7 | EKG impression | | |
| 92846-5 | Ambulatory blood pressure monitor study | | |
| 18754-2 | Ambulatory cardiac rhythm monitor (Holter) study | | |
| 34552-0 | Cardiac 2D echo panel | | |
| 18010-9 | Aorta Diameter by US | | |
| 18018-2 | Left ventricular outflow tract Diameter by US | | |
| 20307-5 | Right ventricular outflow tract Diameter by US 2D | | |
| 29468-6 | Left atrial Diameter anterior-posterior systole by US 2D | | |
| 18083-6 | Left ventricular Internal diameter minor axis diastole by US 2D | | |
| 18085-1 | Left ventricular Internal diameter minor axis systole by US 2D | | |
| 29442-1 | Left ventricular posterior wall Thickness during diastole by US 2D | | |
| 29430-6 | Interventricular septum Thickness during diastole by US 2D | | |
| 8806-2 | Left ventricular Ejection fraction by 2D echo | | |
| 29434-8 | Left ventricular Fractional shortening minor axis by US 2D | | |
| 18147-9 | Central cardiovascular Overall Study observation by US | | |
| 18750-0 | Cardiac electrophysiology study | | |
| 78950-3 | Left ventricle Segmental wall motion panel by Angiogram | | |
| 78951-1 | Left ventricular basal anterior Segmental wall motion by Cardiac angiogram | | |
| 78952-9 | Left ventricular lateral anterior Segmental wall motion by Cardiac angiogram | | |
| 78953-7 | Left ventricular apex Segmental wall motion by Cardiac angiogram | | |
| 78954-5 | Left ventricular inferior Segmental wall motion by Cardiac angiogram | | |
| 78955-2 | Left ventricular basal posterior Segmental wall motion by Cardiac angiogram | | |
| 78956-0 | Ventricular septal Segmental wall motion by Cardiac angiogram | | |
| 78957-8 | Left ventricular lateral posterior Segmental wall motion by Cardiac angiogram | | |
| 82654-5 | Cardiac nuclear imaging SPECT panel | | |
| 82652-9 | Transient ischemic dilation Left ventricle SPECT | | |
| 82651-1 | Washout rate [Ratio] Myocardium SPECT | | |
| 59282-4 | Cardiac stress echo study | | |
| 46213-5 | Tilt table study | | |
| 78895-0 | Coronary angiography panel | | |
| 78897-6 | Percent stenosis of Proximal right coronary artery by Cardiac angiogram | | |
| 78898-4 | Percent stenosis of Mid right coronary artery by Cardiac angiogram | | |
| 78899-2 | Percent stenosis of Distal right coronary artery by Cardiac angiogram | | |
| 78900-8 | Percent stenosis of AV nodal artery by Cardiac angiogram | | |
| 78901-6 | Percent stenosis of Posterior descending branch from right coronary artery by Cardiac angiogram | | |
| 78902-4 | Percent stenosis of Left main coronary artery by Cardiac angiogram | | |
| 78903-2 | Percent stenosis of Proximal left anterior descending artery by Cardiac angiogram | | |
| 78904-0 | Percent stenosis of Mid left anterior descending artery by Cardiac angiogram | | |
| 78905-7 | Percent stenosis of Distal left anterior descending artery by Cardiac angiogram | | |
| 78906-5 | Percent stenosis of First diagonal artery by Cardiac angiogram | | |
| 78907-3 | Percent stenosis of Second diagonal artery by Cardiac angiogram | | |
| 78908-1 | Percent stenosis of Proximal left circumflex artery by Cardiac angiogram | | |
| 78909-9 | Percent stenosis of Obtuse marginal artery by Cardiac angiogram | | |
| 78910-7 | Percent stenosis of Mid and distal left circumflex artery by Cardiac angiogram | | |
| 78911-5 | Percent stenosis of Posterolateral branch from left circumflex artery by Cardiac angiogram | | |
| 78912-3 | Percent stenosis of Posterior descending branch from left circumflex artery by Cardiac angiogram | | |
| 78913-1 | Percent stenosis of Ramus intermedius branch from left main coronary artery by Cardiac angiogram | | |
| 80227-2 | Percent stenosis of Posterolateral branch from right coronary artery | | |
| 80228-0 | Percent stenosis of Additional first diagonal artery | | |
| 80229-8 | Percent stenosis of Additional second diagonal artery | | |
| 78896-8 | Number of diseased coronary segments on Cardiac angiogram | | |
| 64098-7 | Six minute walk test | | |
| 83311-1 | Bone density quantitative measurement by DXA panel | | |
| 46383-6 | DXA Bone [Mass/Area] Bone density | | |
| 24701-5 | DXA Femur [Mass/Area] Bone density | | |
| 38263-0 | DXA Femur [T-score] Bone density | | |
| 80934-3 | DXA Femur [Z-score] Bone density | | |
| 80954-1 | DXA Femur - left [Mass/Area] Bone density | | |
| 80948-3 | DXA Femur - left [T-score] Bone density | | |
| 80940-0 | DXA Femur - left [Z-score] Bone density | | |
| 80953-3 | DXA Femur - right [Mass/Area] Bone density | | |
| 80947-5 | DXA Femur - right [T-score] Bone density | | |
| 80939-2 | DXA Femur - right [Z-score] Bone density | | |
| 38262-2 | DXA Calcaneus [Mass/Area] Bone density | | |
| 38266-3 | DXA Calcaneus [T-score] Bone density | | |
| 80956-6 | DXA Calcaneus - left [Mass/Area] Bone density | | |
| 80950-9 | DXA Calcaneus - left [T-score] Bone density | | |
| 80942-6 | DXA Calcaneus - left [Z-score] Bone density | | |
| 80955-8 | DXA Calcaneus - right [Mass/Area] Bone density | | |
| 80949-1 | DXA Calcaneus - right [T-score] Bone density | | |
| 80941-8 | DXA Calcaneus - right [Z-score] Bone density | | |
| 38261-4 | DXA Hip [Mass/Area] Bone density | | |
| 38264-8 | DXA Hip [T-score] Bone density | | |
| 80933-5 | DXA Hip [Z-score] Bone density | | |
| 46278-8 | DXA Hip - left [Mass/Area] Bone density | | |
| 80946-7 | DXA Hip - left [T-score] Bone density | | |
| 80938-4 | DXA Hip - left [Z-score] Bone density | | |
| 46279-6 | DXA Hip - right [Mass/Area] Bone density | | |
| 80945-9 | DXA Hip - right [T-score] Bone density | | |
| 80937-6 | DXA Hip - right [Z-score] Bone density | | |
| 24966-4 | DXA Lumbar spine [Mass/Area] Bone density | | |
| 38267-1 | DXA Lumbar spine [T-score] Bone density | | |
| 24890-6 | DXA Radius and Ulna [Mass/Area] Bone density | | |
| 38265-5 | DXA Radius and Ulna [T-score] Bone density | | |
| 80932-7 | DXA Radius and Ulna [Z-score] Bone density | | |
| 80952-5 | DXA Radius and Ulna - left [Mass/Area] Bone density | | |
| 80944-2 | DXA Radius and Ulna - left [T-score] Bone density | | |
| 80936-8 | DXA Radius and Ulna - left [Z-score] Bone density | | |
| 80951-7 | DXA Radius and Ulna - right [Mass/Area] Bone density | | |
| 80943-4 | DXA Radius and Ulna - right [T-score] Bone density | | |
| 80935-0 | DXA Radius and Ulna - right [Z-score] Bone density | | |
| 97100-2 | Colonoscopy+US Study | | |
| 28016-4 | ERCP study | | |
| 51393-7 | Esophageal manometry study | | |
| 97101-0 | Flexible sigmoidoscopy+US Study | | |
| 18746-8 | Colonoscopy study | | |
| 18753-4 | Flexible sigmoidoscopy study | | |
| 18751-8 | Endoscopy study | | |
| 11523-8 | EEG study | | |
| 98604-2 | Nerve conduction study panel Nerve | | |
| 98605-9 | Sensory nerve conduction panel Left radial nerve | | |
| 98611-7 | Sensory nerve conduction panel Right radial nerve | | |
| 98617-4 | Sensory nerve conduction panel Left median nerve | | |
| 98622-4 | Sensory nerve conduction panel Right median nerve | | |
| 98627-3 | Sensory nerve conduction panel Left ulnar nerve | | |
| 98632-3 | Sensory nerve conduction panel Right ulnar nerve | | |
| 98637-2 | Sensory nerve conduction panel Left medial antebrachial cutaneous nerve | | |
| 98642-2 | Sensory nerve conduction panel Right medial antebrachial cutaneous nerve | | |
| 98647-1 | Sensory nerve conduction panel Left lateral antebrachial cutaneous nerve | | |
| 98652-1 | Sensory nerve conduction panel Right lateral antebrachial cutaneous nerve | | |
| 18749-2 | Electromyogram study | | |
| 29754-9 | Nystagmogram study | | |
| 92050-4 | Video EEG study | | |
| 98495-5 | Color vision panel | | |
| 79731-6 | Left eye Color vision | | |
| 79730-8 | Right eye Color vision | | |
| 79732-4 | Type of Color vision exam method | | |
| 98496-3 | Color blindness of Eye | | |
| 79894-2 | Electroretinography (ERG) panel | | |
| 79800-9 | ERG ISCEV standard protocol followed | | |
| 79794-4 | ERG study standard procedure followed | | |
| 79791-0 | ERG Reference electrode [Location] | | |
| 79792-8 | Overall study interpretation Right retina by ERG | | |
| 79793-6 | Overall study interpretation Left retina by ERG | | |
| 79773-8 | a-wave amplitude Right retina dark-adapted by ERG | | |
| 79777-9 | a-wave implicit time Right retina dark-adapted by ERG | | |
| 79781-1 | b-wave amplitude Right retina dark-adapted by ERG | | |
| 79786-0 | b-wave implicit time Right retina dark-adapted by ERG | | |
| 79774-6 | a-wave amplitude Left retina dark-adapted by ERG | | |
| 79778-7 | a-wave implicit time Left retina dark-adapted by ERG | | |
| 79782-9 | b-wave amplitude Left retina dark-adapted by ERG | | |
| 79785-2 | b-wave implicit time Left retina dark-adapted by ERG | | |
| 79775-3 | a-wave amplitude Right retina light-adapted by ERG | | |
| 79779-5 | a-wave implicit time Right retina light-adapted by ERG | | |
| 79783-7 | b-wave amplitude Right retina light-adapted by ERG | | |
| 79787-8 | b-wave implicit time Right retina light-adapted by ERG | | |
| 79776-1 | a-wave amplitude Left retina light-adapted by ERG | | |
| 79780-3 | a-wave implicit time Left retina light-adapted by ERG | | |
| 79784-5 | b-wave amplitude Left retina light-adapted by ERG | | |
| 79788-6 | b-wave implicit time Left retina light-adapted by ERG | | |
| 79789-4 | Right retina Oscillatory potentials by ERG | | |
| 79790-2 | Left retina Oscillatory potentials by ERG | | |
| 79795-1 | Flicker response wave amplitude Right retina light-adapted by ERG | | |
| 79797-7 | Flicker response wave implicit time Right retina light-adapted by ERG | | |
| 79796-9 | Flicker response wave amplitude Left retina light-adapted by ERG | | |
| 79798-5 | Flicker response wave implicit time Left retina light-adapted by ERG | | |
| 96189-6 | Right macula Function by ERG | | |
| 96190-4 | Left macula Function by ERG | | |
| 96191-2 | Right optic nerve Function by ERG | | |
| 96192-0 | Left optic nerve Function by ERG | | |
| 96193-8 | Right cones Function by ERG | | |
| 96194-6 | Left cones Function by ERG | | |
| 96195-3 | Right rods Function by ERG | | |
| 96196-1 | Left rods Function by ERG | | |
| 96197-9 | Right cones and rods Function by ERG | | |
| 96198-7 | Left cones and rods Function by ERG | | |
| 96199-5 | Right ganglion cells Function by ERG | | |
| 96200-1 | Left ganglion cells Function by ERG | | |
| 96201-9 | Right optic disc and retinal nerve fiber layer Function by ERG | | |
| 96202-7 | Left optic disc and retinal nerve fiber layer Function by ERG | | |
| 96205-0 | Right optic nerve Function compared to previous assessment by ERG | | |
| 96206-8 | Left optic nerve Function compared to previous assessment by ERG | | |
| 96207-6 | Right macula Function compared to previous assessment by ERG | | |
| 96208-4 | Left macula Function compared to previous assessment by ERG | | |
| 96209-2 | Left rods Function compared to previous assessment by ERG | | |
| 96210-0 | Right rods Function compared to previous assessment by ERG | | |
| 96211-8 | Left cones Function compared to previous assessment by ERG | | |
| 96212-6 | Right cones Function compared to previous assessment by ERG | | |
| 96213-4 | Left cones and rods Function compared to previous assessment by ERG | | |
| 96214-2 | Right cones and rods Function compared to previous assessment by ERG | | |
| 96215-9 | Left ganglion cells Function compared to previous assessment by ERG | | |
| 96216-7 | Right ganglion cells Function compared to previous assessment by ERG | | |
| 96217-5 | Left optic disc and retinal nerve fiber layer Function compared to previous assessment by ERG | | |
| 96218-3 | Right optic disc and retinal nerve fiber layer Function compared to previous assessment by ERG | | |
| 96219-1 | Right retina Functional findings [Interpretation] by ERG | | |
| 96220-9 | Left retina Functional findings [Interpretation] by ERG | | |
| 95298-6 | Keratometry panel | | |
| 28975-1 | Right cornea Axis by Keratometry | | |
| 28985-0 | Left cornea Axis by Keratometry | | |
| 28977-7 | Right cornea Axis 2 by Keratometry | | |
| 28987-6 | Left cornea Axis 2 by Keratometry | | |
| 95300-0 | Axis measurement increment Keratometer | | |
| 28974-4 | Right cornea Base curve 1 by Keratometry | | |
| 28984-3 | Left cornea Base curve 1 by Keratometry | | |
| 28976-9 | Right cornea Base curve 2 by Keratometry | | |
| 28986-8 | Left cornea Base curve 2 by Keratometry | | |
| 28978-5 | Right eye Comment [Interpretation] by Keratometry | | |
| 28988-4 | Left eye Comment [Interpretation] by Keratometry | | |
| 79813-2 | Right cornea Corneal curvature by Keratometry | | |
| 79814-0 | Left cornea Corneal curvature by Keratometry | | |
| 95302-6 | Right cornea Flat curvature radius by Keratometry | | |
| 95305-9 | Left cornea Flat curvature radius by Keratometry | | |
| 95303-4 | Right cornea Steep curvature radius by Keratometry | | |
| 95306-7 | Left cornea Steep curvature radius by Keratometry | | |
| 95304-2 | Right cornea Mean curvature radius by Keratometry | | |
| 95307-5 | Left cornea Mean curvature radius by Keratometry | | |
| 95309-1 | Right cornea Cylinder by Keratometry | | |
| 95311-7 | Left cornea Cylinder by Keratometry | | |
| 95301-8 | Cylinder mode by Keratometry | | |
| 8642-1 | Right pupil Diameter Auto | | |
| 8640-5 | Left pupil Diameter Auto | | |
| 95314-1 | Right pupil Diameter by Keratometry | | |
| 95315-8 | Left pupil Diameter by Keratometry | | |
| 95316-6 | Right cornea Horizontal diameter by Keratometry | | |
| 95317-4 | Left cornea Horizontal diameter by Keratometry | | |
| 28983-5 | Right cornea Longitudinal radius by Keratometry | | |
| 28993-4 | Left cornea Longitudinal radius by Keratometry | | |
| 28994-2 | Right cornea Flat refractive power by Keratometry | | |
| 28996-7 | Left cornea Flat refractive power by Keratometry | | |
| 28995-9 | Right cornea Steep refractive power by Keratometry | | |
| 28997-5 | Left cornea Steep refractive power by Keratometry | | |
| 95308-3 | Right cornea Mean refractive power by Keratometry | | |
| 95310-9 | Left cornea Mean refractive power by Keratometry | | |
| 95299-4 | Type of Refractive power measurement increment | | |
| 28980-1 | Right cornea Sagittal radius.inferior by Keratometry | | |
| 28990-0 | Left cornea Sagittal radius.inferior by Keratometry | | |
| 28982-7 | Right cornea Sagittal radius.nasal by Keratometry | | |
| 28992-6 | Left cornea Sagittal radius.nasal by Keratometry | | |
| 28979-3 | Right cornea Sagittal radius.superior by Keratometry | | |
| 28989-2 | Left cornea Sagittal radius.superior by Keratometry | | |
| 28981-9 | Right cornea Sagittal radius.temporal by Keratometry | | |
| 28991-8 | Left cornea Sagittal radius.temporal by Keratometry | | |
| 95318-2 | Lensmeter panel | | |
| 95319-0 | Corrective lens type | | |
| 95320-8 | Lensmeter Sphere measurement increment | | |
| 95321-6 | Lensmeter Axis measurement increment | | |
| 95322-4 | Cylinder mode | | |
| 95323-2 | Lensmeter Prism measurement increment [Inverse Length] | | |
| 95324-0 | Prism mode | | |
| 95326-5 | Corrective lens Spherical equivalent Calculated | | |
| 95327-3 | Right corrective lens Spherical equivalent Calculated | | |
| 95328-1 | Left corrective lens Spherical equivalent Calculated | | |
| 28814-2 | Corrective lens Add 1 binocular by Lensmeter | | |
| 28810-0 | Right corrective lens Add 1 by Lensmeter | | |
| 28812-6 | Left corrective lens Add 1 by Lensmeter | | |
| 28815-9 | Corrective lens Add 2 binocular by Lensmeter | | |
| 28811-8 | Right corrective lens Add 2 by Lensmeter | | |
| 28813-4 | Left corrective lens Add 2 by Lensmeter | | |
| 95329-9 | Corrective lens Sphere near 1 by Lensmeter | | |
| 28793-8 | Right corrective lens Sphere near 1 by Lensmeter | | |
| 28802-7 | Left corrective lens Sphere near 1 by Lensmeter | | |
| 95330-7 | Corrective lens Sphere near 2 by Lensmeter | | |
| 28796-1 | Right corrective lens Sphere near 2 by Lensmeter | | |
| 28805-0 | Left corrective lens Sphere near 2 by Lensmeter | | |
| 95331-5 | Corrective lens Prism by Lensmeter | | |
| 95332-3 | Right corrective lens Prism by Lensmeter | | |
| 95333-1 | Left corrective lens Prism by Lensmeter | | |
| 95334-9 | Corrective lens Horizontal prism - in by Lensmeter | | |
| 95335-6 | Corrective lens Horizontal prism - out by Lensmeter | | |
| 95336-4 | Right corrective lens Horizontal prism - in by Lensmeter | | |
| 95337-2 | Right corrective lens Horizontal prism - out by Lensmeter | | |
| 95338-0 | Left corrective lens Horizontal prism - in by Lensmeter | | |
| 95339-8 | Left corrective lens Horizontal prism - out by Lensmeter | | |
| 95340-6 | Corrective lens Vertical prism - up by Lensmeter | | |
| 95341-4 | Corrective lens Vertical prism - down by Lensmeter | | |
| 95342-2 | Right corrective lens Vertical prism - up by Lensmeter | | |
| 95343-0 | Right corrective lens Vertical prism - down by Lensmeter | | |
| 95344-8 | Left corrective lens Vertical prism - up by Lensmeter | | |
| 95345-5 | Left corrective lens Vertical prism - down by Lensmeter | | |
| 95346-3 | Corrective lens UV transmittance by Lensmeter | | |
| 95347-1 | Right corrective lens UV transmittance by Lensmeter | | |
| 95348-9 | Left corrective lens UV transmittance by Lensmeter | | |
| 28792-0 | Glasses Pupillary distance.binocular by Lensmeter | | |
| 28782-1 | Right glasses lens Pupillary distance.monocular by Lensmeter | | |
| 28789-6 | Left glasses lens Pupillary distance.monocular by Lensmeter | | |
| 95349-7 | Glasses Pupillary distance.binocular near by Lensmeter | | |
| 28799-5 | Right glasses lens Pupillary distance.monocular near by Lensmeter | | |
| 95350-5 | Left glasses lens Pupillary distance.monocular near by Lensmeter | | |
| 96227-4 | Multifocal electroretinography (mfERG) panel | | |
| 96229-0 | Right macula N1 amplitude--light-adapted by mfERG | | |
| 96228-2 | Left macula N1 amplitude--light-adapted by mfERG | | |
| 96230-8 | Right macula N1 implicit time--light-adapted by mfERG | | |
| 96231-6 | Left macula N1 implicit time--light-adapted by mfERG | | |
| 96238-1 | Right macula P1 amplitude--light-adapted by mfERG | | |
| 96239-9 | Left macula P1 amplitude--light-adapted by mfERG | | |
| 96240-7 | Right macula P1 implicit time--light-adapted by mfERG | | |
| 96241-5 | Left macula P1 implicit time--light-adapted by mfERG | | |
| 96232-4 | Right macula N2 amplitude--light-adapted by mfERG | | |
| 96233-2 | Left macula N2 amplitude--light-adapted by mfERG | | |
| 96234-0 | Right macula N2 implicit time--light-adapted by mfERG | | |
| 96235-7 | Left macula N2 implicit time--light-adapted by mfERG | | |
| 79898-3 | Objective refraction panel | | |
| 79841-3 | Type of Objective refraction method | | |
| 79837-1 | Right eye Sphere--W cycloplegia by Objective refraction | | |
| 79833-0 | Right eye Cylinder--W cycloplegia by Objective refraction | | |
| 79829-8 | Right eye Axis--W cycloplegia by Objective refraction | | |
| 79838-9 | Left eye Sphere--W cycloplegia by Objective refraction | | |
| 79834-8 | Left eye Cylinder--W cycloplegia by Objective refraction | | |
| 79830-6 | Left eye Axis--W cycloplegia by Objective refraction | | |
| 79839-7 | Right eye Sphere--WO cycloplegia by Objective refraction | | |
| 79835-5 | Right eye Cylinder--WO cycloplegia by Objective refraction | | |
| 79831-4 | Right eye Axis--WO cycloplegia by Objective refraction | | |
| 79840-5 | Left eye Sphere--WO cycloplegia by Objective refraction | | |
| 79836-3 | Left eye Cylinder--WO cycloplegia by Objective refraction | | |
| 79832-2 | Left eye Axis--WO cycloplegia by Objective refraction | | |
| 57119-0 | Optical coherence tomography panel | | |
| 57108-3 | Macular grid.center point thickness by OCT | | |
| 57109-1 | Macular grid.center subfield thickness by OCT | | |
| 57110-9 | Macular grid.inner superior subfield thickness by OCT | | |
| 57111-7 | Macular grid.inner nasal subfield thickness by OCT | | |
| 57112-5 | Macular grid.inner inferior subfield thickness by OCT | | |
| 57113-3 | Macular grid.inner temporal subfield thickness by OCT | | |
| 57114-1 | Macular grid.outer superior subfield thickness by OCT | | |
| 57115-8 | Macular grid.outer nasal subfield thickness by OCT | | |
| 57116-6 | Macular grid.outer inferior subfield thickness by OCT | | |
| 57117-4 | Macular grid.outer temporal subfield thickness by OCT | | |
| 57118-2 | Macular grid.total volume by OCT | | |
| 96246-4 | Pattern electroretinography (PERG) panel | | |
| 96236-5 | Right retina N95 amplitude--light-adapted by PERG | | |
| 96237-3 | Left retina N95 amplitude--light-adapted by PERG | | |
| 96242-3 | Right retina P50 amplitude--light-adapted by PERG | | |
| 96243-1 | Left retina P50 amplitude--light-adapted by PERG | | |
| 96244-9 | Right retina--light-adapted by PERG | | |
| 96245-6 | Left retina--light-adapted by PERG | | |
| 79895-9 | Subjective refraction panel | | |
| 79854-6 | Type of Subjective refraction method | | |
| 79850-4 | Right eye Sphere--W cycloplegia by Subjective refraction | | |
| 79846-2 | Right eye Cylinder--W cycloplegia by Subjective refraction | | |
| 79842-1 | Right eye Axis--W cycloplegia by Subjective refraction | | |
| 79851-2 | Left eye Sphere--W cycloplegia by Subjective refraction | | |
| 79847-0 | Left eye Cylinder--W cycloplegia by Subjective refraction | | |
| 79843-9 | Left eye Axis--W cycloplegia by Subjective refraction | | |
| 79852-0 | Right eye Sphere--WO cycloplegia by Subjective refraction | | |
| 79848-8 | Right eye Cylinder--WO cycloplegia by Subjective refraction | | |
| 79844-7 | Right eye Axis--WO cycloplegia by Subjective refraction | | |
| 79853-8 | Left eye Sphere--WO cycloplegia by Subjective refraction | | |
| 79849-6 | Left eye Cylinder--WO cycloplegia by Subjective refraction | | |
| 79845-4 | Left eye Axis--WO cycloplegia by Subjective refraction | | |
| 79896-7 | Tonometry panel | | |
| 79764-7 | Type of Tonometer | | |
| 79892-6 | Right eye Intraocular pressure | | |
| 79893-4 | Left eye Intraocular pressure | | |
| 98497-1 | Visual acuity panel | | |
| 98498-9 | Visual acuity uncorrected Left eye | | |
| 98499-7 | Visual acuity uncorrected Right eye | | |
| 98500-2 | Visual acuity.binocular uncorrected Eye | | |
| 98501-0 | Visual acuity near uncorrected Left eye | | |
| 98502-8 | Visual acuity near uncorrected Right eye | | |
| 98503-6 | Visual acuity.binocular near uncorrected Eye | | |
| 98504-4 | Visual acuity far uncorrected Left eye | | |
| 98505-1 | Visual acuity far uncorrected Right eye | | |
| 98506-9 | Visual acuity.binocular far uncorrected Eye | | |
| 65893-0 | Visual acuity best corrected Right eye | | |
| 65897-1 | Visual acuity best corrected Left eye | | |
| 98507-7 | Visual acuity.binocular best corrected Eye | | |
| 98508-5 | Visual acuity near best corrected Left eye | | |
| 98509-3 | Visual acuity near best corrected Right eye | | |
| 98510-1 | Visual acuity.binocular near best corrected Eye | | |
| 98511-9 | Visual acuity far best corrected Left eye | | |
| 98512-7 | Visual acuity far best corrected Right eye | | |
| 98513-5 | Visual acuity.binocular far best corrected Eye | | |
| 79908-0 | Type of Visual acuity exam method | | |
| 77199-8 | Evoked potential study | | |
| 89015-2 | Pure tone threshold audiometry panel | | |
| 91375-6 | Hearing threshold Ear - left --250 Hz | | |
| 89024-4 | Hearing threshold Ear - left --500 Hz | | |
| 91379-8 | Hearing threshold Ear - left --750 Hz | | |
| 89016-0 | Hearing threshold Ear - left --1000 Hz | | |
| 91373-1 | Hearing threshold Ear - left --1500 Hz | | |
| 89018-6 | Hearing threshold Ear - left --2000 Hz | | |
| 89020-2 | Hearing threshold Ear - left --3000 Hz | | |
| 89022-8 | Hearing threshold Ear - left --4000 Hz | | |
| 91377-2 | Hearing threshold Ear - left --5000 Hz | | |
| 89026-9 | Hearing threshold Ear - left --6000 Hz | | |
| 89028-5 | Hearing threshold Ear - left --8000 Hz | | |
| 91374-9 | Hearing threshold Ear - right --250 Hz | | |
| 89025-1 | Hearing threshold Ear - right --500 Hz | | |
| 91378-0 | Hearing threshold Ear - right --750 Hz | | |
| 89017-8 | Hearing threshold Ear - right --1000 Hz | | |
| 91372-3 | Hearing threshold Ear - right --1500 Hz | | |
| 89019-4 | Hearing threshold Ear - right --2000 Hz | | |
| 89021-0 | Hearing threshold Ear - right --3000 Hz | | |
| 89023-6 | Hearing threshold Ear - right --4000 Hz | | |
| 91376-4 | Hearing threshold Ear - right --5000 Hz | | |
| 89027-7 | Hearing threshold Ear - right --6000 Hz | | |
| 89029-3 | Hearing threshold Ear - right --8000 Hz | | |
| 18744-3 | Bronchoscopy study | | |
| 81459-0 | Spirometry panel | | |
| 90568-7 | Polysomnography panel | | |
| 90565-3 | Respiratory effort-related arousal index | | |
| 90557-0 | Respiratory effort-related arousal [#] | | |
| 90563-8 | Obstructive apnea hypopnea index | | |
| 90559-6 | Apnea + hypopnea [#] | | |
| 90560-4 | Obstructive apnea [#] | | |
| 90552-1 | Mixed apnea [#] | | |
| 90553-9 | Central apnea [#] | | |
| 90561-2 | Hypopnea index | | |
| 90555-4 | Hypopnea [#] | | |
| 90556-2 | Obstructive hypopnea [#] | | |
| 90564-6 | Central apnea hypopnea index | | |
| 90558-8 | Central hypopnea [#] | | |
| 90562-0 | Apnea index | | |
| 90566-1 | Respiratory disturbance index | | |
| 90554-7 | Oxygen desaturation [#] | | |
| 90567-9 | Oxygen desaturation index | | |
| 81458-2 | Pulmonary function test panel | | |
| 81440-0 | Vital capacity [Volume] Respiratory system --pre bronchodilation | | |
| 81441-8 | Vital capacity [Volume] Respiratory system --post bronchodilation | | |
| 81456-6 | Functional residual capacity --pre bronchodilation | | |
| 81457-4 | Functional residual capacity --post bronchodilation | | |
| 81452-5 | Residual volume --pre bronchodilation | | |
| 81453-3 | Residual volume --post bronchodilation | | |
| 81450-9 | Total lung capacity --pre bronchodilation | | |
| 81451-7 | Total lung capacity --post bronchodilation | | |
| 81454-1 | Residual volume/Total capacity --pre bronchodilation | | |
| 81455-8 | Residual volume/Total capacity --post bronchodilation | | |
| 81448-3 | Inspiratory gas flow.max Respiratory system airway --pre bronchodilation | | |
| 81449-1 | Inspiratory gas flow.max Respiratory system airway --post bronchodilation | | |
| 81446-7 | Maximum expiratory pressure Respiratory system --pre bronchodilation | | |
| 81447-5 | Maximum expiratory pressure Respiratory system --post bronchodilation | | |
| 81444-2 | Maximum inspiratory pressure Respiratory system --pre bronchodilation | | |
| 81445-9 | Maximum inspiratory pressure Respiratory system --post bronchodilation | | |
| 81443-4 | Airway resistance --pre bronchodilation | | |
| 81442-6 | Airway resistance --post bronchodilation | | |
| 80525-9 | Uroflowmetry panel | | |
| 80519-2 | Maximum Urine flow by Uroflowmetry | | |
| 80526-7 | Time to max urine flow by Uroflowmetry | | |
| 80523-4 | Urine output by Uroflowmetry | | |
| 80520-0 | Flow time by Uroflowmetry | | |
| 80524-2 | Voiding time by Uroflowmetry | | |
| 80522-6 | Mean urine flow by Uroflowmetry | | |
| 9197-5 | Urine output --post void | | |
| 80521-8 | Uroflowmetry study | | |
| 45033-8 | Cardiovascular physiologic and EKG assessment panel | | |
| 44974-4 | Pulse intensity of Unspecified artery palpation | | |
| 8910-2 | Pulse intensity Radial artery - left by palpation | | |
| 8911-0 | Pulse intensity Radial artery - right by palpation | | |
| 44964-5 | Capillary refill [Time] of Chest | | |
| 44963-7 | Capillary refill [Time] of Nail bed | | |
| 44970-2 | Cardiac monitor interpretation Narrative | | |
| 39129-2 | Moisture of Skin | | |
| 44972-8 | Edema site | | |
| 44966-0 | Edema | | |
| 44967-8 | Electrocardiograph lead | | |
| 8884-9 | Heart rate rhythm | | |
| 44962-9 | Homans sign of Lower extremity - left | | |
| 44961-1 | Homans sign of Lower extremity - right | | |
| 69428-1 | Jugular vein distension | | |
| 44965-2 | Jugular vein distention --head raised 30 degrees | | |
| 44976-9 | P-R Interval {Electrocardiograph lead} | | |
| 18523-1 | P-R Interval Lead I | | |
| 18524-9 | P-R Interval Lead II | | |
| 18525-6 | P-R Interval Lead III | | |
| 44973-6 | QRS duration {Electrocardiograph lead} | | |
| 9952-3 | QRS duration in lead I | | |
| 9953-1 | QRS duration in lead II | | |
| 65681-9 | Treatment for your glaucoma [PhenX] | | |
| 44975-1 | Q-T interval {Electrocardiograph lead} | | |
| 18535-5 | Q-T interval Lead I | | |
| 18537-1 | Q-T interval Lead III | | |
| 44968-6 | Temperature of Skin palpation | | |
| 1-8 | | Acyclovir [Susceptibility] | |
| 10-9 | | Amdinocillin [Susceptibility] by Serum bactericidal titer | |
| 100-8 | | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) | |
| 1000-9 | | DBG Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10000-8 | | R wave duration in lead AVR | |
| 100002-5 | | Specimen care is maintained | |
| 100003-3 | | Team communication is maintained throughout care | |
| 100004-1 | | Demonstrates knowledge of the expected psychosocial responses to the procedure | |
| 100005-8 | | Demonstrates knowledge of nutritional management related to the procedure | |
| 100006-6 | | Demonstrates knowledge of medication management | |
| 100007-4 | | Demonstrates knowledge of pain management | |
| 100008-2 | | Demonstrates knowledge of wound management | |
| 100009-0 | | Demonstrates knowledge of the procedure and expected results | |
| 10001-6 | | R wave duration in lead I | |
| 100010-8 | | No injury related to procedure equipment, medical supplies, or instrumentation | |
| 100011-6 | | No injury related to an electrical source | |
| 100012-4 | | Participates in decisions affecting the patient's plan of care | |
| 100013-2 | | Participates in the discharge process | |
| 100014-0 | | Psychosocial health is maintained at or improved from baseline | |
| 100015-7 | | No injury related to positioning due to care or procedure | |
| 100016-5 | | No injury related to a laser source | |
| 100017-3 | | Perioperative nursing data set outcomes panel [PNDS] | |
| 100018-1 | | Hospice care Note | |
| 100019-9 | | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 10002-4 | | R wave duration in lead II | |
| 100020-7 | | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100021-5 | | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100022-3 | | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100023-1 | | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100024-9 | | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100025-6 | | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100026-4 | | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100027-2 | | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100028-0 | | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100029-8 | | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method | |
| 10003-2 | | R wave duration in lead III | |
| 100030-6 | | Axis I: Temporal aspects score [Mainz Pain Staging System] | |
| 100031-4 | | Axis II: Spatial aspects score [Mainz Pain Staging System] | |
| 100032-2 | | Axis III: Drug taking behavior score [Mainz Pain Staging System] | |
| 100033-0 | | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] | |
| 100034-8 | | Provider of automated external defibrillator use | |
| 100035-5 | | Exam finding location of Chest | |
| 100036-3 | | Exam finding location of Lung | |
| 100037-1 | | Patient contact disposition EMS unit | |
| 100038-9 | | Patient evaluation disposition EMS unit | |
| 100039-7 | | Crew disposition for patient care EMS unit | |
| 10004-0 | | R wave duration in lead V1 | |
| 100040-5 | | Patient transport disposition EMS unit | |
| 100041-3 | | Aminoglycoside [Susceptibility] | |
| 100042-1 | | Atovaquone [Susceptibility] | |
| 100043-9 | | Azithromycin+Ethambutol [Susceptibility] | |
| 100044-7 | | Cefcapene [Susceptibility] | |
| 100045-4 | | Cefozopran [Susceptibility] | |
| 100046-2 | | Cefquinome [Susceptibility] | |
| 100047-0 | | Cefteram [Susceptibility] | |
| 100048-8 | | Clarithromycin+Ethambutol [Susceptibility] | |
| 100049-6 | | Eravacycline [Susceptibility] | |
| 10005-7 | | R wave duration in lead V2 | |
| 100050-4 | | Erythromycin+Ethambutol [Susceptibility] | |
| 100051-2 | | Ethambutol+rifAMPin [Susceptibility] | |
| 100052-0 | | Flomoxef [Susceptibility] | |
| 100053-8 | | Fluoroquinolone [Susceptibility] | |
| 100054-6 | | Gamithromycin [Susceptibility] | |
| 100055-3 | | Optochin [Susceptibility] | |
| 100056-1 | | Panipenem [Susceptibility] | |
| 100057-9 | | Prothionamide [Susceptibility] | |
| 100058-7 | | Prulifloxacin [Susceptibility] | |
| 100059-5 | | Rifapentine [Susceptibility] | |
| 10006-5 | | R wave duration in lead V3 | |
| 100060-3 | | Tildipirosin [Susceptibility] | |
| 100061-1 | | Tosufloxacin [Susceptibility] | |
| 100062-9 | | Standard Dermatology Outcome Measures panel | |
| 100063-7 | | Primary skin concern | |
| 100064-5 | | Itch severity Reporting Period - Reported | |
| 100065-2 | | Satisfied with treatment | |
| 100066-0 | | Specular microscopy panel | |
| 100067-8 | | Eye Image magnification | |
| 100068-6 | | Right eye Fixation point [Angle] | |
| 100069-4 | | Left eye Fixation point [Angle] | |
| 10007-3 | | R wave duration in lead V4 | |
| 100070-2 | | Right cornea Cell density | |
| 100071-0 | | Left cornea Cell density | |
| 100072-8 | | Right cornea Coefficient of variation | |
| 100073-6 | | Left cornea Coefficient of variation | |
| 100074-4 | | Right cornea Hexagonality | |
| 100075-1 | | Left cornea Hexagonality | |
| 100076-9 | | Right cornea Endothelial cells counted | |
| 100077-7 | | Left cornea Endothelial cells counted | |
| 100078-5 | | Right cornea Endothelial cell area.min | |
| 100079-3 | | Left cornea Endothelial cell area.min | |
| 10008-1 | | R wave duration in lead V5 | |
| 100080-1 | | Right cornea Endothelial cell area.max | |
| 100081-9 | | Left cornea Endothelial cell area.max | |
| 100082-7 | | Right cornea Endothelial cell area.mean | |
| 100083-5 | | Left cornea Endothelial cell area.mean | |
| 100084-3 | | Right cornea Cell area.standard deviation | |
| 100085-0 | | Left cornea Cell area.standard deviation | |
| 100086-8 | | Right cornea Type of Analysis method by Specular microscopy | |
| 100087-6 | | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100088-4 | | Taenia solium larva Ab bands panel - Serum by Immunoblot | |
| 100089-2 | | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot | |
| 10009-9 | | R wave duration in lead V6 | |
| 100090-0 | | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot | |
| 100091-8 | | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay | |
| 100092-6 | | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot | |
| 100093-4 | | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100094-2 | | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100095-9 | | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100096-7 | | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100097-5 | | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100098-3 | | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100099-1 | | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot | |
| 1001-7 | | DBG Ab [Presence] in Serum or Plasma from Donor | |
| 10010-7 | | R' wave amplitude in lead AVF | |
| 100100-7 | | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay | |
| 100101-5 | | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100102-3 | | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100103-1 | | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100104-9 | | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100105-6 | | Filaria IgG and IgM panel - Serum | |
| 100106-4 | | Filaria IgG Ab [Presence] in Serum by Immunoassay | |
| 100107-2 | | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay | |
| 100108-0 | | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay | |
| 100109-8 | | Leishmania sp Ab bands panel - Serum by Immunoblot | |
| 10011-5 | | R' wave amplitude in lead AVL | |
| 100110-6 | | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100111-4 | | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100112-2 | | Fasciola sp Ab bands panel - Serum by Immunoblot | |
| 100113-0 | | Helicobacter pylori Ab panel - Serum | |
| 100114-8 | | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot | |
| 100115-5 | | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot | |
| 100116-3 | | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot | |
| 100117-1 | | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot | |
| 100118-9 | | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot | |
| 100119-7 | | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot | |
| 10012-3 | | R' wave amplitude in lead AVR | |
| 100120-5 | | Chlamydia trachomatis Ab panel - Serum | |
| 100121-3 | | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay | |
| 100122-1 | | Chlamydophila pneumoniae Ab panel - Serum | |
| 100123-9 | | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay | |
| 100124-7 | | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay | |
| 100125-4 | | Chlamydophila psittaci Ab panel - Serum | |
| 100126-2 | | Bordetella pertussis Ab.IgG panel - Serum | |
| 100127-0 | | Campylobacter sp Ab panel - Serum | |
| 100128-8 | | Cryptococcus sp Ag panel - Serum | |
| 100129-6 | | Schistosoma sp Ab [Titer] in Serum by Hemagglutination | |
| 10013-1 | | R' wave amplitude in lead I | |
| 100130-4 | | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot | |
| 100131-2 | | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot | |
| 100132-0 | | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot | |
| 100133-8 | | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot | |
| 100134-6 | | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot | |
| 100135-3 | | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot | |
| 100136-1 | | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot | |
| 100137-9 | | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot | |
| 100138-7 | | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot | |
| 100139-5 | | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot | |
| 10014-9 | | R' wave amplitude in lead II | |
| 100140-3 | | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot | |
| 100141-1 | | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot | |
| 100142-9 | | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot | |
| 100143-7 | | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot | |
| 100144-5 | | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot | |
| 100145-2 | | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot | |
| 100146-0 | | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot | |
| 100147-8 | | Toxoplasma gondii Ab bands panel - Serum by Immunoblot | |
| 100148-6 | | Schistosoma sp Ab bands panel - Serum by Immunoblot | |
| 100149-4 | | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma | |
| 10015-6 | | R' wave amplitude in lead III | |
| 100150-2 | | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma | |
| 100151-0 | | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma | |
| 100152-8 | | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | |
| 100153-6 | | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | |
| 100154-4 | | Specimen collection supervision level | |
| 100155-1 | | Left cornea Type of Analysis method by Specular microscopy | |
| 100156-9 | | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection | |
| 100157-7 | | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing | |
| 100158-5 | | Microalbumin [Mass/volume] in Urine collected for unspecified duration | |
| 100159-3 | | Knee Society Score pre-op panel [Knee Society Score] | |
| 10016-4 | | R' wave amplitude in lead V1 | |
| 100160-1 | | Knee replacement | |
| 100161-9 | | Charnley Functional Classification | |
| 100162-7 | | Knee alignment W standing X-ray measured | |
| 100163-5 | | Knee medial AndOr lateral instability W full extension | |
| 100164-3 | | Knee AP instability W 90 degree flexion | |
| 100165-0 | | Knee range of motion | |
| 100166-8 | | Flexion contracture range of Knee | |
| 100167-6 | | Extensor lag range of Knee | |
| 100168-4 | | Knee pain severity with level walking | |
| 100169-2 | | Knee pain severity with stairs or inclines | |
| 10017-2 | | R' wave amplitude in lead V2 | |
| 100170-0 | | Knee feels normal | |
| 100171-8 | | Satisfaction with level of knee pain while sitting | |
| 100172-6 | | Satisfaction with level of knee pain while lying in bed | |
| 100173-4 | | Satisfaction with knee function while getting out of bed | |
| 100174-2 | | Satisfaction with knee function while performing light household duties | |
| 100175-9 | | Satisfaction with knee function while performing recreational activities | |
| 100176-7 | | Expect surgery to relieve pain | |
| 100177-5 | | Expect surgery will improve ability to perform activities of daily living | |
| 100178-3 | | Expect surgery will improve ability to perform leisure, recreational, or sports activities | |
| 100179-1 | | Walk without assistive mobility devices | |
| 10018-0 | | R' wave amplitude in lead V3 | |
| 100180-9 | | Assistive mobility devices used | |
| 100181-7 | | Assistive mobility devices used due to health condition | |
| 100182-5 | | Duration of standing before sitting due to knee discomfort | |
| 100183-3 | | Duration of walking before stopping due to knee discomfort | |
| 100184-1 | | How bothersome is knee when walking on an uneven surface | |
| 100185-8 | | How bothersome is knee when turning or pivoting leg | |
| 100186-6 | | How bothersome is knee when climbing up or down a flight of stairs | |
| 100187-4 | | How bothersome is knee when getting up from a low seat without armrests | |
| 100188-2 | | How bothersome is knee when getting into or out of a car | |
| 100189-0 | | How bothersome is knee when moving laterally | |
| 10019-8 | | R' wave amplitude in lead V4 | |
| 100190-8 | | How bothersome is knee when climbing a ladder or step stool | |
| 100191-6 | | How bothersome is knee when carrying a bag for one block | |
| 100192-4 | | How bothersome is knee when squatting | |
| 100193-2 | | How bothersome is knee when kneeling | |
| 100194-0 | | How bothersome is knee when running | |
| 100195-7 | | Pain severity--during activity | |
| 100196-5 | | Pre-op total score [Knee Society Score] | |
| 100197-3 | | Exercise activity and pain severity panel | |
| 100198-1 | | Pre-op objective knee indicators score [Knee Society Score] | |
| 100199-9 | | Pre-op symptoms score [Knee Society Score] | |
| 1002-5 | | DBG Ab [Presence] in Serum or Plasma | |
| 10020-6 | | R' wave amplitude in lead V5 | |
| 100200-5 | | Pre-op patient expectations score [Knee Society Score] | |
| 100201-3 | | Pre-op functional activities score [Knee Society Score] | |
| 100202-1 | | Pre-op discretionary knee activities score [Knee Society Score] | |
| 100203-9 | | Knee Society Score post-op panel [Knee Society Score] | |
| 100204-7 | | Accuracy of pre-surgery expectations of pain relief | |
| 100205-4 | | Accuracy of pre-surgery expectations to perform activities of daily living | |
| 100206-2 | | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities | |
| 100207-0 | | Post-op total score [Knee Society Score] | |
| 100208-8 | | Post-op objective knee indicators score [Knee Society Score] | |
| 100209-6 | | Post-op symptoms score [Knee Society Score] | |
| 10021-4 | | R' wave amplitude in lead V6 | |
| 100210-4 | | Post-op patient expectations score [Knee Society Score] | |
| 100211-2 | | Post-op functional activities score [Knee Society Score] | |
| 100212-0 | | Post-op discretionary knee activities score [Knee Society Score] | |
| 100213-8 | | Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method | |
| 100214-6 | | Dental model prior authorization Document | |
| 100215-3 | | Episode of care medical records Document Transplant surgery | |
| 100216-1 | | Surgical synoptic report | |
| 100217-9 | | Surgical oncology synoptic report | |
| 100218-7 | | Surgical oncology of colon synoptic report | |
| 100219-5 | | Surgical oncology of melanoma synoptic report | |
| 10022-2 | | R' wave duration in lead AVF | |
| 100220-3 | | Surgical oncology of breast synoptic report | |
| 100221-1 | | Surgical oncology of thyroid synoptic report | |
| 100222-9 | | Surgical oncology of pancreas synoptic report | |
| 100223-7 | | Physical findings of Retina Narrative | |
| 100224-5 | | Cardiac left ventricular segmental wall motion by echo panel | |
| 100225-2 | | Bone density quantitative ultrasound study | |
| 100226-0 | | Small bowel capsule endoscopy study Document | |
| 100227-8 | | Colon capsule endoscopy study Document | |
| 100228-6 | | Upper gastrointestinal capsule endoscopy study Document | |
| 100229-4 | | Endoscopic ultrasound study Document | |
| 10023-0 | | R' wave duration in lead AVL | |
| 100230-2 | | Routine prenatal assessment panel | |
| 100231-0 | | Endobronchial ultrasound study | |
| 100232-8 | | Impacts of Events Scale-Revised panel | |
| 100233-6 | | Reminders brought back feelings about adverse event | |
| 100234-4 | | Trouble staying asleep | |
| 100235-1 | | Other things triggered persistent thoughts about adverse event | |
| 100236-9 | | Felt irritable AndOr angry | |
| 100237-7 | | Avoided getting upset when unintentionally thought about adverse event | |
| 100238-5 | | Thought about adverse event unintentionally | |
| 100239-3 | | Felt as if adverse event did not happen | |
| 10024-8 | | R' wave duration in lead AVR | |
| 100240-1 | | Avoided reminders of adverse event | |
| 100241-9 | | Experienced mental images of adverse event | |
| 100242-7 | | Easily startled | |
| 100243-5 | | Tried to not think of adverse event | |
| 100244-3 | | Aware of feelings about adverse event, but did not address them | |
| 100245-0 | | Feelings about adverse event were numb | |
| 100246-8 | | Acted or felt the same as during adverse event | |
| 100247-6 | | Trouble falling asleep | |
| 100248-4 | | Waves of strong feelings about adverse event | |
| 100249-2 | | Tried to remove adverse event from memory | |
| 10025-5 | | R' wave duration in lead I | |
| 100250-0 | | Trouble concentrating | |
| 100251-8 | | Reminders of adverse event caused physical reactions | |
| 100252-6 | | Had dreams about adverse event | |
| 100253-4 | | Felt watchful and on-guard | |
| 100254-2 | | Tried not to talk about adverse event | |
| 100255-9 | | Total score [Impact of Event Scale-Revised] | |
| 100256-7 | | Fallen in last 6 months | |
| 100257-5 | | Feel unsteady when standing or walking | |
| 100258-3 | | History of fall related injury | |
| 100259-1 | | Aware of tactile sensations | |
| 10026-3 | | R' wave duration in lead II | |
| 100260-9 | | Easy to describe thoughts AndOr feelings | |
| 100261-7 | | Critical of own thoughts AndOr feelings | |
| 100262-5 | | Able to notice distressing thoughts AndOr feelings without having to react | |
| 100263-3 | | Easily distracted | |
| 100264-1 | | Able to notice thoughts AndOr feelings without being overwhelmed | |
| 100265-8 | | Aware of dietary intake impact on self | |
| 100266-6 | | Difficult to describe thoughts AndOr feelings | |
| 100267-4 | | Aware of auditory stimuli | |
| 100268-2 | | Able to avoid immediate reaction in difficult situations | |
| 100269-0 | | Do things without paying attention | |
| 10027-1 | | R' wave duration in lead III | |
| 100270-8 | | Recover quickly from distressing thoughts AndOr images | |
| 100271-6 | | Aware of olfactory stimuli | |
| 100272-4 | | Aware of visual stimuli | |
| 100273-2 | | Aware of emotions affect on thoughts AndOr behavior | |
| 100274-0 | | Observing score [FFMQ] | |
| 100275-7 | | Describing score [FFMQ] | |
| 100276-5 | | Acting with awareness score [FFMQ] | |
| 100277-3 | | Nonjudging score [FFMQ] | |
| 100278-1 | | Nonreactivity score [FFMQ] | |
| 100279-9 | | Total score [FFMQ] | |
| 10028-9 | | R' wave duration in lead V1 | |
| 100280-7 | | Five Facet Mindfulness Questionnaire panel [FFMQ] | |
| 100281-5 | | D Ab [Units/volume] in Serum or Plasma | |
| 100282-3 | | Vaccine exemption certificate | |
| 100283-1 | | Harris Hip Score panel [Harris Hip Score] | |
| 100284-9 | | Walking - functional ability | |
| 100285-6 | | Comfortable seated position | |
| 100286-4 | | Able to board public transportation | |
| 100287-2 | | Put on shoes and socks | |
| 100288-0 | | Absence of deformity score [Harris Hip Score] | |
| 100289-8 | | Absence of hip deformity measurements | |
| 10029-7 | | R' wave duration in lead V2 | |
| 100290-6 | | Range of motion score [Harris Hip Score] | |
| 100291-4 | | Total score [Harris Hip Score] | |
| 100292-2 | | Pre-op patient satisfaction score [Knee Society Score] | |
| 100293-0 | | Hip Flexion range of motion | |
| 100294-8 | | Hip Abduction range of motion | |
| 100295-5 | | Hip Adduction range of motion | |
| 100296-3 | | Hip External rotation range of motion | |
| 100297-1 | | Hip Internal rotation range of motion | |
| 100298-9 | | Repetition count | |
| 100299-7 | | Post-op patient satisfaction score [Knee Society Score] | |
| 1003-3 | | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma | |
| 10030-5 | | R' wave duration in lead V3 | |
| 100300-3 | | End time Unspecified body region | |
| 100301-1 | | Start time Unspecified body region | |
| 100302-9 | | Time period start and end panel Unspecified body region | |
| 100303-7 | | Condition certainty of presence | |
| 100304-5 | | Flights climbed [#] Reporting Period | |
| 100305-2 | | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method | |
| 100306-0 | | IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method | |
| 100307-8 | | Behavioral screening elder mistreatment | |
| 100308-6 | | Need help getting to essential places | |
| 100309-4 | | Activity support person | |
| 10031-3 | | R' wave duration in lead V4 | |
| 100310-2 | | Reliability of support person | |
| 100311-0 | | Need help to make sure there is enough food, medicines or any other things needed in house | |
| 100312-8 | | Person or persons that makes sure there is enough food, medicines or any other things needed in house | |
| 100313-6 | | Need help with household things such as cook meals, help feed, or provide correct medicines each day | |
| 100314-4 | | Need help with house cleaning or yard work | |
| 100315-1 | | Need help getting out of bed, showered, or dressed | |
| 100316-9 | | Need help to make sure bills get paid | |
| 100317-7 | | Relationship of usual support person for daily activities | |
| 100318-5 | | Have help with finances AndOr financial decisions | |
| 100319-3 | | Relationship of financial support person | |
| 10032-1 | | R' wave duration in lead V5 | |
| 100320-1 | | Financial support person usually asks for permission before making decisions | |
| 100321-9 | | Financial support person usually makes good decisions about finances | |
| 100322-7 | | Have access to paperwork for financial decisions made | |
| 100323-5 | | Financial support person forged signature | |
| 100324-3 | | Coercion of financial support person for signing a document in order to get money or possessions | |
| 100325-0 | | Experienced theft by support person | |
| 100326-8 | | Money spent or property sold without permission | |
| 100327-6 | | Stranger forged signature for financial gain | |
| 100328-4 | | Stranger forced document signature for financial gain | |
| 100329-2 | | Feared for safety due to verbal attack | |
| 10033-9 | | R' wave duration in lead V6 | |
| 100330-0 | | Felt humiliated due to ridicule | |
| 100331-8 | | Coerced to do something | |
| 100332-6 | | Ignored by close friend or relative for extended period | |
| 100333-4 | | Physically hit or threatened | |
| 100334-2 | | Been physically hurt with some degree of injury | |
| 100335-9 | | Coerced sexual activity | |
| 100336-7 | | Coerced touching of private body parts of self or others | |
| 100337-5 | | Coerced to undress or expose private body area | |
| 100338-3 | | Photographed in any degree of nudity without consent | |
| 100339-1 | | Experienced attempted physical restraint | |
| 10034-7 | | S wave amplitude in lead AVF | |
| 100340-9 | | Range of motion panel Hip | |
| 100341-7 | | Rubella virus IgG Ab index [Units/volume] in Serum and CSF | |
| 100342-5 | | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry | |
| 100343-3 | | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | |
| 100344-1 | | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | |
| 100345-8 | | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection | |
| 100346-6 | | Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG | |
| 100347-4 | | Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG | |
| 100348-2 | | Model for end-stage liver disease sodium score | |
| 100349-0 | | US.doppler Penis vessels W vasodilator IV | |
| 10035-4 | | S wave amplitude in lead AVL | |
| 100350-8 | | Sesamum indicum 1 IgE Ab [Units/volume] in Serum | |
| 100351-6 | | Pioglitazone [Presence] in Serum or Plasma | |
| 100352-4 | | Rosiglitazone [Presence] in Serum or Plasma | |
| 100353-2 | | Norwalk Community Health Center Screening Tool [NCHC] | |
| 100354-0 | | Frequency of participating in multi-modal communication without assistance | |
| 100355-7 | | Frequency of participating in spoken language expression communication without assistance | |
| 100356-5 | | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection | |
| 100357-3 | | Naloxone [Presence] in Cord tissue by Screen method | |
| 100358-1 | | Phentermine [Presence] in Cord tissue by Screen method | |
| 100359-9 | | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay | |
| 10036-2 | | S wave amplitude in lead AVR | |
| 100360-7 | | Brief Resilience Scale panel [BRS] | |
| 100361-5 | | Quickly recover from bad events | |
| 100362-3 | | Difficulty making it through stressful events | |
| 100363-1 | | Easily recover from a stressful event | |
| 100364-9 | | Difficulty recovering from bad events | |
| 100365-6 | | Easily recover from difficulties | |
| 100366-4 | | Lengthy recovery from setbacks | |
| 100367-2 | | Total Score BRS | |
| 100368-0 | | Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS | |
| 100369-8 | | NM Thyroid gland Views W Tl-201 IV | |
| 10037-0 | | S wave amplitude in lead I | |
| 100370-6 | | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection | |
| 100371-4 | | Titin Ab [Units/volume] in Serum by Immunoassay | |
| 100372-2 | | Abiraterone [Mass/volume] in Serum or Plasma | |
| 100373-0 | | Eucheuma IgG Ab [Units/volume] in Serum | |
| 100374-8 | | Aloe vera IgG Ab [Units/volume] in Serum | |
| 100375-5 | | Anise IgG Ab [Units/volume] in Serum | |
| 100376-3 | | Bambusa vulgaris IgG Ab [Units/volume] in Serum | |
| 100377-1 | | Goat cheese IgG Ab [Units/volume] in Serum | |
| 100378-9 | | Sheep cheese IgG Ab [Units/volume] in Serum | |
| 100379-7 | | Leeks IgG Ab [Units/volume] in Serum | |
| 10038-8 | | S wave amplitude in lead II | |
| 100380-5 | | Red cabbage IgG Ab [Units/volume] in Serum | |
| 100381-3 | | Mentha balsamea Wild IgG Ab [Units/volume] in Serum | |
| 100382-1 | | FDA package insert REMS addressed risk | |
| 100383-9 | | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | |
| 100384-7 | | Rapeseed IgG Ab [Units/volume] in Serum | |
| 100385-4 | | Corn salad IgG Ab [Units/volume] in Serum | |
| 100386-2 | | Rosemary IgG Ab [Units/volume] in Serum | |
| 100387-0 | | Poppy Seed IgG Ab [Units/volume] in Serum | |
| 100388-8 | | Cocoa IgG Ab [Units/volume] in Serum | |
| 100389-6 | | Pistachio IgG Ab [Units/volume] in Serum | |
| 10039-6 | | S wave amplitude in lead III | |
| 100390-4 | | Sunflower Seed IgG Ab [Units/volume] in Serum | |
| 100391-2 | | Dates IgG Ab [Units/volume] in Serum | |
| 100392-0 | | Duck meat IgG Ab [Units/volume] in Serum | |
| 100393-8 | | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum | |
| 100394-6 | | Astacoidea IgG Ab [Units/volume] in Serum | |
| 100395-3 | | Carob IgG Ab [Units/volume] in Serum | |
| 100396-1 | | Brassica napus IgG Ab [Units/volume] in Serum | |
| 100397-9 | | Goat Meat IgG Ab [Units/volume] in Serum | |
| 100398-7 | | Goose meat IgG Ab [Units/volume] in Serum | |
| 100399-5 | | Ostrich meat IgG Ab [Units/volume] in Serum | |
| 1004-1 | | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells | |
| 10040-4 | | S wave amplitude in lead V1 | |
| 100400-1 | | Quail meat IgG Ab [Units/volume] in Serum | |
| 100401-9 | | Rabbit meat IgG Ab [Units/volume] in Serum | |
| 100402-7 | | Venison meat IgG Ab [Units/volume] in Serum | |
| 100403-5 | | Guineafowl IgG Ab [Units/volume] in Serum | |
| 100404-3 | | Horse meat IgG Ab [Units/volume] in Serum | |
| 100405-0 | | Kefir IgG Ab [Units/volume] in Serum | |
| 100406-8 | | Butter IgG Ab [Units/volume] in Serum | |
| 100407-6 | | Camembert cheese IgG Ab [Units/volume] in Serum | |
| 100408-4 | | Emmental cheese IgG Ab [Units/volume] in Serum | |
| 100409-2 | | Processed cheese IgG Ab [Units/volume] in Serum | |
| 10041-2 | | S wave amplitude in lead V2 | |
| 100410-0 | | Curd cheese IgG Ab [Units/volume] in Serum | |
| 100411-8 | | Sugar Beet IgG Ab [Units/volume] in Serum | |
| 100412-6 | | Chinese cabbage IgG Ab [Units/volume] in Serum | |
| 100413-4 | | Fennel Fresh IgG Ab [Units/volume] in Serum | |
| 100414-2 | | Gourd IgG Ab [Units/volume] in Serum | |
| 100415-9 | | Kale IgG Ab [Units/volume] in Serum | |
| 100416-7 | | Savoy cabbage IgG Ab [Units/volume] in Serum | |
| 100417-5 | | Vitis sp leaf IgG Ab [Units/volume] in Serum | |
| 100418-3 | | Liquorice IgG Ab [Units/volume] in Serum | |
| 100419-1 | | Snow pea IgG Ab [Units/volume] in Serum | |
| 10042-0 | | S wave amplitude in lead V3 | |
| 100420-9 | | Fava bean IgG Ab [Units/volume] in Serum | |
| 100421-7 | | Chick Pea IgG Ab [Units/volume] in Serum | |
| 100422-5 | | Chicory IgG Ab [Units/volume] in Serum | |
| 100423-3 | | Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum | |
| 100424-1 | | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma | |
| 100425-8 | | DiHydro T-Mas [Mass/volume] in Serum or Plasma | |
| 100426-6 | | Squalene [Mass/volume] in Serum or Plasma | |
| 100427-4 | | Stigmasterol [Mass/volume] in Serum or Plasma | |
| 100428-2 | | Carnitine free and total and acylcarnitine panel - Urine | |
| 100429-0 | | LRBA deficiency panel - Blood | |
| 10043-8 | | S wave amplitude in lead V4 | |
| 100430-8 | | Cells.LRBA+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) | |
| 100431-6 | | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) | |
| 100432-4 | | Cells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) | |
| 100433-2 | | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) | |
| 100434-0 | | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection | |
| 100435-7 | | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay | |
| 100436-5 | | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay | |
| 100437-3 | | Norsufentanil [Mass/volume] in Urine by Confirmatory method | |
| 100438-1 | | Adolescent medicine Outpatient Progress note | |
| 100439-9 | | Allergy and Immunology Outpatient Progress note | |
| 10044-6 | | S wave amplitude in lead V5 | |
| 100440-7 | | Allergy Outpatient Progress note | |
| 100441-5 | | Attending Outpatient Progress note | |
| 100442-3 | | Audiology Outpatient Progress note | |
| 100443-1 | | Bariatric surgery Outpatient Progress note | |
| 100444-9 | | Blood banking and transfusion medicine Outpatient Progress note | |
| 100445-6 | | Bone Marrow Transplant Outpatient Progress note | |
| 100446-4 | | Breastfeeding Outpatient Progress note | |
| 100447-2 | | Burn management Outpatient Progress note | |
| 100448-0 | | Cardiac surgery Outpatient Progress note | |
| 100449-8 | | Cardiopulmonary Outpatient Progress note | |
| 10045-3 | | S wave amplitude in lead V6 | |
| 100450-6 | | Child and adolescent psychiatry Outpatient Progress note | |
| 100451-4 | | Chiropractic medicine Outpatient Progress note | |
| 100452-2 | | Clinical cardiac electrophysiology Outpatient Progress note | |
| 100453-0 | | Clinical genetics Outpatient Progress note | |
| 100454-8 | | Clinical neurophysiology Outpatient Progress note | |
| 100455-5 | | Clinical pathology Outpatient Progress note | |
| 100456-3 | | Colon and rectal surgery Outpatient Progress note | |
| 100457-1 | | Consultant Outpatient Progress note | |
| 100458-9 | | Outpatient COVID-19 Intubation Progress note | |
| 100459-7 | | Outpatient COVID-19 Progress note | |
| 10046-1 | | S wave duration in lead AVF | |
| 100460-5 | | Dermatology Outpatient Progress note | |
| 100461-3 | | Developmental-behavioral pediatrics Outpatient Progress note | |
| 100462-1 | | Dialysis and Therapeutic apheresis Outpatient Progress note | |
| 100463-9 | | Eating disorders Outpatient Progress note | |
| 100464-7 | | Endocrinology Outpatient Progress note | |
| 100465-4 | | Family medicine Outpatient Progress note | |
| 100466-2 | | Gastroenterology Outpatient Progress note | |
| 100467-0 | | Geriatric medicine Outpatient Progress note | |
| 100468-8 | | Gynecologic oncology Outpatient Progress note | |
| 100469-6 | | Gynecology Outpatient Progress note | |
| 10047-9 | | S wave duration in lead AVL | |
| 100470-4 | | Healthcare navigator Outpatient Progress note | |
| 100471-2 | | Heart failure Outpatient Progress note | |
| 100472-0 | | Heart failure+Transplant cardiology Outpatient Progress note | |
| 100473-8 | | Hematology Outpatient Progress note | |
| 100474-6 | | Hematology+Medical oncology Outpatient Progress note | |
| 100475-3 | | Hepatology Outpatient Progress note | |
| 100476-1 | | Immunology Outpatient Progress note | |
| 100477-9 | | Infectious disease Outpatient Progress note | |
| 100478-7 | | Internal medicine Outpatient Progress note | |
| 100479-5 | | Interventional cardiology Outpatient Progress note | |
| 10048-7 | | S wave duration in lead AVR | |
| 100480-3 | | Interventional radiology Outpatient Progress note | |
| 100481-1 | | Outpatient Mechanical circulatory support Progress note | |
| 100482-9 | | Medical Aid in Dying Outpatient Progress note | |
| 100483-7 | | Mental health Outpatient Progress note | |
| 100484-5 | | Multi-specialty program Outpatient Progress note | |
| 100485-2 | | Neonatal perinatal medicine Outpatient Progress note | |
| 100486-0 | | Nephrology Outpatient Progress note | |
| 100487-8 | | Neurological surgery Outpatient Progress note | |
| 100488-6 | | Neurology Outpatient Progress note | |
| 100489-4 | | Neurology with special qualifications in child neurology Outpatient Progress note | |
| 10049-5 | | S wave duration in lead I | |
| 100490-2 | | Nurse practitioner Outpatient Progress note | |
| 100491-0 | | Nurse Outpatient Progress note | |
| 100492-8 | | Nutrition and dietetics Outpatient Progress note | |
| 100493-6 | | Obstetrics and Gynecology Outpatient Progress note | |
| 100494-4 | | Obstetrics Outpatient Progress note | |
| 100495-1 | | Occupational therapy Outpatient Progress note | |
| 100496-9 | | Oncology Outpatient Progress note | |
| 100497-7 | | Ophthalmology Outpatient Progress note | |
| 100498-5 | | Optometry Outpatient Progress note | |
| 100499-3 | | Oral and Maxillofacial Surgery Outpatient Progress note | |
| 1005-8 | | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma | |
| 10050-3 | | S wave duration in lead II | |
| 100500-8 | | Orthopaedic surgery Outpatient Progress note | |
| 100501-6 | | Orthotics prosthetics Outpatient Progress note | |
| 100502-4 | | Otolaryngology Outpatient Progress note | |
| 100503-2 | | Pain medicine Outpatient Progress note | |
| 100504-0 | | Palliative care Outpatient Progress note | |
| 100505-7 | | Pediatric cardiology Outpatient Progress note | |
| 100506-5 | | Pediatric dermatology Outpatient Progress note | |
| 100507-3 | | Pediatric endocrinology Outpatient Progress note | |
| 100508-1 | | Pediatric gastroenterology Outpatient Progress note | |
| 100509-9 | | Pediatric hematology-oncology Outpatient Progress note | |
| 10051-1 | | S wave duration in lead III | |
| 100510-7 | | Pediatric infectious diseases Outpatient Progress note | |
| 100511-5 | | Pediatric otolaryngology Outpatient Progress note | |
| 100512-3 | | Pediatric pulmonology Outpatient Progress note | |
| 100513-1 | | Pediatric rheumatology Outpatient Progress note | |
| 100514-9 | | Pediatric surgery Outpatient Progress note | |
| 100515-6 | | Pediatric transplant hepatology Outpatient Progress note | |
| 100516-4 | | Pediatric urology Outpatient Progress note | |
| 100517-2 | | Pharmacogenomics Outpatient Progress note | |
| 100518-0 | | Physical medicine and rehab Outpatient Progress note | |
| 100519-8 | | Physical therapy Outpatient Progress note | |
| 10052-9 | | S wave duration in lead V1 | |
| 100520-6 | | Plastic surgery Outpatient Progress note | |
| 100521-4 | | Podiatry Outpatient Progress note | |
| 100522-2 | | Psychiatry Hospital Progress note | |
| 100523-0 | | Psychology Outpatient Progress note | |
| 100524-8 | | Pulmonary Outpatient Progress note | |
| 100525-5 | | Radiation oncology Outpatient Progress note | |
| 100526-3 | | Radiology Outpatient Progress note | |
| 100527-1 | | Recreational therapy Outpatient Progress note | |
| 100528-9 | | Reproductive endocrinology and infertility Outpatient Progress note | |
| 100529-7 | | Research Outpatient Progress note | |
| 10053-7 | | S wave duration in lead V2 | |
| 100530-5 | | Rheumatology Outpatient Progress note | |
| 100531-3 | | Sleep medicine Outpatient Progress note | |
| 100532-1 | | Social worker Outpatient Progress note | |
| 100533-9 | | Solid Organ Transplant Outpatient Progress note | |
| 100534-7 | | Speech-language pathology Outpatient Progress note | |
| 100535-4 | | Spinal surgery Outpatient Progress note | |
| 100536-2 | | Sports medicine Outpatient Progress note | |
| 100537-0 | | Surgery of the hand Outpatient Progress note | |
| 100538-8 | | Telehealth+Outpatient Progress note | |
| 100539-6 | | Thromboembolism Outpatient Progress note | |
| 10054-5 | | S wave duration in lead V3 | |
| 100540-4 | | Transplant surgery Outpatient Progress note | |
| 100541-2 | | Trauma Outpatient Progress note | |
| 100542-0 | | Urology Outpatient Progress note | |
| 100543-8 | | Vascular neurology Outpatient Progress note | |
| 100544-6 | | Vascular surgery Outpatient Progress note | |
| 100545-3 | | Wound care management Outpatient Progress note | |
| 100546-1 | | Wound, Ostomy, and Continence Care Outpatient Progress note | |
| 100547-9 | | Adolescent medicine Hospital Progress note | |
| 100548-7 | | Allergy and Immunology Hospital Progress note | |
| 100549-5 | | Allergy Hospital Progress note | |
| 10055-2 | | S wave duration in lead V4 | |
| 100550-3 | | Attending Hospital Progress note | |
| 100551-1 | | Audiology Hospital Progress note | |
| 100552-9 | | Bariatric surgery Hospital Progress note | |
| 100553-7 | | Blood banking and transfusion medicine Hospital Progress note | |
| 100554-5 | | Bone Marrow Transplant Hospital Progress note | |
| 100555-2 | | Breastfeeding Hospital Progress note | |
| 100556-0 | | Burn management Hospital Progress note | |
| 100557-8 | | Cardiac surgery Hospital Progress note | |
| 100558-6 | | Cardiopulmonary Hospital Progress note | |
| 100559-4 | | Child and adolescent psychiatry Hospital Progress note | |
| 10056-0 | | S wave duration in lead V5 | |
| 100560-2 | | Clinical cardiac electrophysiology Hospital Progress note | |
| 100561-0 | | Clinical genetics Hospital Progress note | |
| 100562-8 | | Clinical neurophysiology Hospital Progress note | |
| 100563-6 | | Clinical pathology Hospital Progress note | |
| 100564-4 | | Colon and rectal surgery Hospital Progress note | |
| 100565-1 | | Consultant Hospital Progress note | |
| 100566-9 | | Dentistry Hospital Progress note | |
| 100567-7 | | Dermatology Hospital Progress note | |
| 100568-5 | | Developmental-behavioral pediatrics Hospital Progress note | |
| 100569-3 | | Dialysis and Therapeutic apheresis Hospital Progress note | |
| 10057-8 | | S wave duration in lead V6 | |
| 100570-1 | | Eating disorders Hospital Progress note | |
| 100571-9 | | Endocrinology Hospital Progress note | |
| 100572-7 | | Family medicine Hospital Progress note | |
| 100573-5 | | Gastroenterology Hospital Progress note | |
| 100574-3 | | General medicine Hospital Progress note | |
| 100575-0 | | Geriatric medicine Hospital Progress note | |
| 100576-8 | | Gynecologic oncology Hospital Progress note | |
| 100577-6 | | Gynecology Hospital Progress note | |
| 100578-4 | | Healthcare navigator Hospital Progress note | |
| 100579-2 | | Heart failure Hospital Progress note | |
| 10058-6 | | S' wave amplitude in lead AVF | |
| 100580-0 | | Heart failure+Transplant cardiology Hospital Progress note | |
| 100581-8 | | Hematology Hospital Progress note | |
| 100582-6 | | Hematology+Medical oncology Hospital Progress note | |
| 100583-4 | | Hepatology Hospital Progress note | |
| 100584-2 | | Immunology Hospital Progress note | |
| 100585-9 | | Infectious disease Hospital Progress note | |
| 100586-7 | | Internal medicine Hospital Progress note | |
| 100587-5 | | Interventional cardiology Hospital Progress note | |
| 100588-3 | | Interventional radiology Hospital Progress note | |
| 100589-1 | | Hospital Mechanical circulatory support Progress note | |
| 10059-4 | | S' wave amplitude in lead AVL | |
| 100590-9 | | Medical Aid in Dying Hospital Progress note | |
| 100591-7 | | Mental health Hospital Progress note | |
| 100592-5 | | Multi-specialty program Hospital Progress note | |
| 100593-3 | | Neonatal perinatal medicine Hospital Progress note | |
| 100594-1 | | Nephrology Hospital Progress note | |
| 100595-8 | | Neurological surgery Hospital Progress note | |
| 100596-6 | | Neurology Hospital Progress note | |
| 100597-4 | | Neurology with special qualifications in child neurology Hospital Progress note | |
| 100598-2 | | Nurse practitioner Hospital Progress note | |
| 100599-0 | | Nurse Hospital Progress note | |
| 1006-6 | | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells | |
| 10060-2 | | S' wave amplitude in lead AVR | |
| 100600-6 | | Nutrition and dietetics Hospital Progress note | |
| 100601-4 | | Obstetrics and Gynecology Hospital Progress note | |
| 100602-2 | | Obstetrics Hospital Progress note | |
| 100603-0 | | Occupational therapy Hospital Progress note | |
| 100604-8 | | Oncology Hospital Progress note | |
| 100605-5 | | Ophthalmology Hospital Progress note | |
| 100606-3 | | Oral and Maxillofacial Surgery Hospital Progress note | |
| 100607-1 | | Orthopaedic surgery Hospital Progress note | |
| 100608-9 | | Orthotics prosthetics Hospital Progress note | |
| 100609-7 | | Otolaryngology Hospital Progress note | |
| 10061-0 | | S' wave amplitude in lead I | |
| 100610-5 | | Pain medicine Hospital Progress note | |
| 100611-3 | | Palliative care Hospital Progress note | |
| 100612-1 | | Pastoral care Hospital Progress note | |
| 100613-9 | | Pediatric cardiology Hospital Progress note | |
| 100614-7 | | Pediatric dermatology Hospital Progress note | |
| 100615-4 | | Pediatric endocrinology Hospital Progress note | |
| 100616-2 | | Pediatric gastroenterology Hospital Progress note | |
| 100617-0 | | Pediatric hematology-oncology Hospital Progress note | |
| 100618-8 | | Pediatric infectious diseases Hospital Progress note | |
| 100619-6 | | Pediatric otolaryngology Hospital Progress note | |
| 10062-8 | | S' wave amplitude in lead II | |
| 100620-4 | | Pediatric pulmonology Hospital Progress note | |
| 100621-2 | | Pediatric rheumatology Hospital Progress note | |
| 100622-0 | | Pediatric surgery Hospital Progress note | |
| 100623-8 | | Pediatric transplant hepatology Hospital Progress note | |
| 100624-6 | | Pharmacogenomics Hospital Progress note | |
| 100625-3 | | Pharmacology Hospital Progress note | |
| 100626-1 | | Physical medicine and rehab Hospital Progress note | |
| 100627-9 | | Physical therapy Hospital Progress note | |
| 100628-7 | | Plastic surgery Hospital Progress note | |
| 100629-5 | | Podiatry Hospital Progress note | |
| 10063-6 | | S' wave amplitude in lead III | |
| 100630-3 | | Psychology Hospital Progress note | |
| 100631-1 | | Radiation oncology Hospital Progress note | |
| 100632-9 | | Radiology Hospital Progress note | |
| 100633-7 | | Rapid response team Hospital Progress note | |
| 100634-5 | | Recreational therapy Hospital Progress note | |
| 100635-2 | | Reproductive endocrinology and infertility Hospital Progress note | |
| 100636-0 | | Research Hospital Progress note | |
| 100637-8 | | Rheumatology Hospital Progress note | |
| 100638-6 | | Sleep medicine Hospital Progress note | |
| 100639-4 | | Social worker Hospital Progress note | |
| 10064-4 | | S' wave amplitude in lead V1 | |
| 100640-2 | | Solid Organ Transplant Hospital Progress note | |
| 100641-0 | | Speech-language pathology Hospital Progress note | |
| 100642-8 | | Spinal surgery Hospital Progress note | |
| 100643-6 | | Surgery of the hand Hospital Progress note | |
| 100644-4 | | Thromboembolism Hospital Progress note | |
| 100645-1 | | Trauma Hospital Progress note | |
| 100646-9 | | Urology Hospital Progress note | |
| 100647-7 | | Vascular neurology Hospital Progress note | |
| 100648-5 | | Vascular surgery Hospital Progress note | |
| 100649-3 | | Wound care management Hospital Progress note | |
| 10065-1 | | S' wave amplitude in lead V2 | |
| 100650-1 | | Wound, Ostomy, and Continence Care Hospital Progress note | |
| 100651-9 | | Hospital COVID-19 Intubation Progress note | |
| 100652-7 | | Pure tone bone conduction threshold audiometry panel | |
| 100653-5 | | Pure tone air conduction threshold audiometry panel | |
| 100654-3 | | Pyruvate kinase M2 [Presence] in Stool | |
| 100655-0 | | XR Sella turcica Lateral | |
| 100656-8 | | Maternal and fetal medicine Outpatient Progress note | |
| 100657-6 | | Maternal and fetal medicine Telephone encounter+Hospital Progress note | |
| 100658-4 | | Hospital COVID-19 Progress note | |
| 100659-2 | | Maternal and fetal medicine Hospital Progress note | |
| 10066-9 | | S' wave amplitude in lead V3 | |
| 100660-0 | | Maternal and fetal medicine Telephone encounter+Outpatient Progress note | |
| 100661-8 | | Psychiatry Outpatient Progress note | |
| 100662-6 | | Cortisol free and total panel - Serum or Plasma | |
| 100663-4 | | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method | |
| 100664-2 | | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method | |
| 100665-9 | | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method | |
| 100666-7 | | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method | |
| 100667-5 | | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method | |
| 100668-3 | | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method | |
| 100669-1 | | NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method | |
| 10067-7 | | S' wave amplitude in lead V4 | |
| 100670-9 | | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus | |
| 100671-7 | | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection | |
| 100672-5 | | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection | |
| 100673-3 | | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection | |
| 100674-1 | | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100675-8 | | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection | |
| 100676-6 | | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection | |
| 100677-4 | | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
| 100678-2 | | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100679-0 | | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
| 10068-5 | | S' wave amplitude in lead V5 | |
| 100680-8 | | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100681-6 | | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
| 100682-4 | | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100683-2 | | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
| 100684-0 | | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100685-7 | | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
| 100686-5 | | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | |
| 100687-3 | | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection | |
| 100688-1 | | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100689-9 | | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection | |
| 10069-3 | | S' wave amplitude in lead V6 | |
| 100690-7 | | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection | |
| 100691-5 | | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100692-3 | | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | |
| 100693-1 | | Pneumocystis jiroveci DNA [Log #/volume] in Respiratory specimen by NAA with probe detection | |
| 100694-9 | | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method | |
| 100695-6 | | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative | |
| 100696-4 | | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal | |
| 100697-2 | | Interventional radiology Outpatient Note | |
| 100698-0 | | Social Determinants of Health screening report Document | |
| 100699-8 | | Rifabutin+Ethambutol [Susceptibility] | |
| 1007-4 | | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells | |
| 10070-1 | | S' wave duration in lead AVF | |
| 100700-4 | | Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection | |
| 100701-2 | | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection | |
| 100702-0 | | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection | |
| 100703-8 | | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection | |
| 100704-6 | | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection | |
| 100705-3 | | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection | |
| 100706-1 | | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection | |
| 100707-9 | | Polymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count | |
| 100708-7 | | Plasma cells/100 leukocytes in Synovial fluid | |
| 100709-5 | | Hepatocellular carcinoma risk [Score] by GAAD | |
| 10071-9 | | S' wave duration in lead AVL | |
| 100710-3 | | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection | |
| 100711-1 | | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay | |
| 100712-9 | | Brexpiprazole [Mass/volume] in Serum or Plasma | |
| 100713-7 | | Cariprazine [Mass/volume] in Serum or Plasma | |
| 100714-5 | | Guanfacine [Mass/volume] in Serum or Plasma | |
| 100715-2 | | Prothipendyl [Mass/volume] in Serum or Plasma | |
| 100716-0 | | Prostate specific Ag [Mass/volume] in DBS | |
| 100717-8 | | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method | |
| 100718-6 | | Undersea and hyperbaric medicine Discharge summary | |
| 100719-4 | | Surgical oncology Discharge summary | |
| 10072-7 | | S' wave duration in lead AVR | |
| 100720-2 | | Reproductive endocrinology and infertility Discharge summary | |
| 100721-0 | | Community health care Discharge summary | |
| 100722-8 | | Integrative medicine Discharge summary | |
| 100723-6 | | Sports medicine Discharge summary | |
| 100724-4 | | Diabetology Discharge summary | |
| 100725-1 | | Optometry Discharge summary | |
| 100726-9 | | Podiatry Discharge summary | |
| 100727-7 | | Chiropractic medicine Discharge summary | |
| 100728-5 | | Cardiac surgery Discharge summary | |
| 100729-3 | | Breastfeeding Discharge summary | |
| 10073-5 | | S' wave duration in lead I | |
| 100730-1 | | Transplant surgery Discharge summary | |
| 100731-9 | | Urgent care center Discharge summary | |
| 100732-7 | | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum | |
| 100733-5 | | Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a) | |
| 100734-3 | | traMADol and Metabolites Panel - Urine by Confirmatory method | |
| 100735-0 | | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes | |
| 100736-8 | | Acylcarnitine Analysis Post Mortem in Specimen Document | |
| 100737-6 | | Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma | |
| 100738-4 | | Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma | |
| 100739-2 | | Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma | |
| 10074-3 | | S' wave duration in lead II | |
| 100740-0 | | Amylase.macromolecular [Presence] in Serum or Plasma | |
| 100741-8 | | Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma | |
| 100742-6 | | Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma | |
| 100743-4 | | Lipase.macromolecular [Presence] in Serum or Plasma | |
| 100744-2 | | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis | |
| 100745-9 | | Chloride [Moles/volume] in Mixed venous blood | |
| 100746-7 | | Glucose [Moles/volume] in Mixed venous blood | |
| 100747-5 | | Legionella serogroup panel - Specimen | |
| 100748-3 | | Legionella spp [Presence] in Specimen by NAA with probe detection | |
| 100749-1 | | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection | |
| 10075-0 | | S' wave duration in lead III | |
| 100750-9 | | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection | |
| 100751-7 | | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma | |
| 100752-5 | | Exacerbating factors - Reported | |
| 100753-3 | | Alleviating factors - Reported | |
| 100754-1 | | Platelet disorders multigene analysis in Blood or Tissue by Sequencing | |
| 100755-8 | | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing | |
| 100756-6 | | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing | |
| 100757-4 | | Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing | |
| 100758-2 | | Estimated lung age by based on clinical data | |
| 100759-0 | | Inspiratory reserve [Volume] Respiratory system by Spirometry | |
| 10076-8 | | S' wave duration in lead V1 | |
| 100760-8 | | XR Radius and Ulna - left Single view | |
| 100761-6 | | PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | |
| 100762-4 | | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method | |
| 100763-2 | | Mycobacterium sp comparative reaction interpretation Narrative | |
| 100764-0 | | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal | |
| 100765-7 | | Homocysteine and methylmalonate and methylcitrate panel - DBS | |
| 100766-5 | | Center for Epidemiologic Studies Depression Scale panel [CES-D] | |
| 100767-3 | | Bothered by things that are not usually bothersome | |
| 100768-1 | | Poor appetite | |
| 100769-9 | | Unhappy even with help from my family or friends | |
| 10077-6 | | S' wave duration in lead V2 | |
| 100770-7 | | Feeling just as good as others | |
| 100771-5 | | Trouble focusing | |
| 100772-3 | | Feeling depressed | |
| 100773-1 | | Feeling everything is too much of an effort | |
| 100774-9 | | Feeling hopeful about the future | |
| 100775-6 | | Feeling life had been a failure | |
| 100776-4 | | Feeling fearful | |
| 100777-2 | | Restless sleep | |
| 100778-0 | | Feeling happy | |
| 100779-8 | | Quieter than usual | |
| 10078-4 | | S' wave duration in lead V3 | |
| 100780-6 | | Feeling lonely | |
| 100781-4 | | People were unfriendly | |
| 100782-2 | | Enjoying life | |
| 100783-0 | | Crying spells | |
| 100784-8 | | Feeling sad | |
| 100785-5 | | Feeling people dislike me | |
| 100786-3 | | Lack of energy | |
| 100787-1 | | Total Score CES-D | |
| 100788-9 | | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum | |
| 100789-7 | | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum | |
| 10079-2 | | S' wave duration in lead V4 | |
| 100790-5 | | Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum | |
| 100791-3 | | Hamster epithelium IgG Ab [Mass/volume] in Serum | |
| 100792-1 | | Forsythia IgE Ab [Units/volume] in Serum | |
| 100793-9 | | Testosterone [Mass/volume] in Body fluid | |
| 100794-7 | | Follitropin [Units/volume] in Body fluid | |
| 100795-4 | | S100 calcium binding protein B [Mass/volume] in Body fluid | |
| 100796-2 | | Thyroglobulin [Mass/volume] in Body fluid | |
| 100797-0 | | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge | |
| 100798-8 | | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge | |
| 100799-6 | | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge | |
| 1008-2 | | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma | |
| 10080-0 | | S' wave duration in lead V5 | |
| 100800-2 | | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge | |
| 100801-0 | | 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge | |
| 100802-8 | | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge | |
| 100803-6 | | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge | |
| 100804-4 | | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge | |
| 100805-1 | | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge | |
| 100806-9 | | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge | |
| 100807-7 | | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge | |
| 100808-5 | | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge | |
| 100809-3 | | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge | |
| 10081-8 | | S' wave duration in lead V6 | |
| 100810-1 | | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge | |
| 100811-9 | | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge | |
| 100812-7 | | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge | |
| 100813-5 | | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge | |
| 100814-3 | | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge | |
| 100815-0 | | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge | |
| 100816-8 | | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | |
| 100817-6 | | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | |
| 100818-4 | | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge | |
| 100819-2 | | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge | |
| 10082-6 | | ST initial amplitude 6 ms in lead AVF | |
| 100820-0 | | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge | |
| 100821-8 | | National POLST form: portable medical order panel | |
| 100822-6 | | Cardiopulmonary resuscitation orders | |
| 100823-4 | | Initial portable medical treatment orders | |
| 100824-2 | | Additional portable medical orders or instructions | |
| 100825-9 | | Medically assisted nutrition orders | |
| 100826-7 | | Portable medical order AndOr advance directive review | |
| 100827-5 | | Portable medical order discussion participants | |
| 100828-3 | | Portable medical order administrative information | |
| 100829-1 | | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge | |
| 10083-4 | | ST initial amplitude 6 ms in lead AVL | |
| 100830-9 | | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge | |
| 100831-7 | | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge | |
| 100832-5 | | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge | |
| 100833-3 | | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge | |
| 100834-1 | | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge | |
| 100835-8 | | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge | |
| 100836-6 | | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge | |
| 100837-4 | | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | |
| 100838-2 | | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | |
| 100839-0 | | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma | |
| 10084-2 | | ST initial amplitude 6 ms in lead AVR | |
| 100840-8 | | IgE [Units/volume] in Body fluid | |
| 100841-6 | | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot | |
| 100842-4 | | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST | |
| 100843-2 | | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ | |
| 100844-0 | | Liver fibrosis score in Serum or Plasma by Calculated.Agile4 | |
| 100845-7 | | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) | |
| 100846-5 | | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay | |
| 100847-3 | | Gas and ammonia panel - Arterial blood | |
| 100848-1 | | Cell count and Differential panel - Amniotic fluid by Manual count | |
| 100849-9 | | Leukocytes [#/volume] in Amniotic fluid by Manual count | |
| 10085-9 | | ST initial amplitude 6 ms in lead I | |
| 100850-7 | | Neutrophils [#/volume] in Amniotic fluid by Manual count | |
| 100851-5 | | Other cells [#/volume] in Amniotic fluid by Manual count | |
| 100852-3 | | NM Bones Views for metastasis W Sr-89 IV | |
| 100853-1 | | NM Pericardial space Pericardial effusion | |
| 100854-9 | | Lymphocytes/100 cells in Blood mononuclear cells by Immunoassay | |
| 100855-6 | | CD3 cells/100 cells in Blood mononuclear cells | |
| 100856-4 | | CD3+CD4+ (T4 helper) cells/100 cells in Blood mononuclear cells | |
| 100857-2 | | CD3+CD8+ (T8 suppressor) cells/100 cells in Blood mononuclear cells | |
| 100858-0 | | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | |
| 100859-8 | | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | |
| 10086-7 | | ST initial amplitude 6 ms in lead II | |
| 100860-6 | | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | |
| 100861-4 | | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | |
| 100862-2 | | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | |
| 100863-0 | | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | |
| 100864-8 | | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method | |
| 100865-5 | | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection | |
| 100866-3 | | Febrile antibody profile in Serum | |
| 100867-1 | | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay | |
| 100868-9 | | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method | |
| 100869-7 | | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method | |
| 10087-5 | | ST initial amplitude 6 ms in lead III | |
| 100870-5 | | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method | |
| 100871-3 | | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method | |
| 100872-1 | | Bacteria producing polysaccharide from sucrose [Presence] in Isolate | |
| 100873-9 | | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method | |
| 100874-7 | | Basidiobolus sp [Presence] in Specimen | |
| 100875-4 | | Fetal Heart Document limited US | |
| 100876-2 | | Fetal Heart Document US | |
| 100877-0 | | US Heart Transesophageal during surgery | |
| 100878-8 | | Endoscopic ultrasound study Upper GI tract Document | |
| 100879-6 | | US Guidance for cryoablation of Breast - right | |
| 10088-3 | | ST initial amplitude 6 ms in lead V1 | |
| 100880-4 | | US Guidance for cryoablation of Breast - left | |
| 100881-2 | | MR Guidance for cryoablation of Bone | |
| 100882-0 | | MR Peritoneum W contrast percutaneous intraperitoneal | |
| 100883-8 | | MR Guidance for biopsy of Kidney - left | |
| 100884-6 | | MR Guidance for biopsy of Kidney - right | |
| 100885-3 | | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection | |
| 100886-1 | | Orf virus DNA [Presence] in Specimen by NAA with probe detection | |
| 100887-9 | | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection | |
| 100888-7 | | West African monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | |
| 100889-5 | | Congo Basin monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | |
| 10089-1 | | ST initial amplitude 6 ms in lead V2 | |
| 100890-3 | | Poxvirus DNA panel | |
| 100891-1 | | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay | |
| 100892-9 | | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay | |
| 100893-7 | | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma | |
| 100894-5 | | Recommended screening frequency Narrative | |
| 100895-2 | | Rickettsia conorii IgG and IgM [Interpretation] in Serum | |
| 100896-0 | | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge | |
| 100897-8 | | Staphylococcus aureus [Presence] in Specimen by Organism specific culture | |
| 100898-6 | | Lipid panel - Serum or Plasma | |
| 100899-4 | | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture | |
jurisdiction[0]
Concept